| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/22/2009 | US7592359 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2503767C Pyridopyrrolizine and pyridoindolizine derivatives |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2396720C Thiazolyl amide derivatives |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/17/2009 | WO2009113810A2 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases |
| 09/17/2009 | WO2009113736A1 Mmp-2 and/or mmp-9 inhibitor |
| 09/17/2009 | WO2009113665A1 Method of producing drug for swine atrophic rhinitis |
| 09/17/2009 | WO2009113664A1 Recombinant dermonecrotic toxoid-containing drug for swine atrophic rhinitis |
| 09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | WO2009112954A2 Processes for the preparation of bosentan and related compounds using novel intermediates |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112679A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112678A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112473A1 Novel compounds |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2009111947A1 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 09/17/2009 | WO2009111838A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | WO2009048326A3 Preparation for treatment of a pulmonary disease |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | US20090233904 Macrocyclic Spiro Pyrimidine Derivatives |
| 09/17/2009 | US20090233878 Novel adenosine a3 receptor agonists |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233363 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/17/2009 | US20090232895 Procedure and devices for the controlled obtaining of dry saline aerosols with therapeutic effect |
| 09/17/2009 | US20090232850 Therapeutic treatments using botulinum neurotoxin |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232802 Compositions and methods for the treatment of natural killer cell related diseases |
| 09/17/2009 | DE202008012494U1 Pharmazeutische Zusammensetzung für die nasale Applikation A pharmaceutical composition for nasal administration |
| 09/17/2009 | CA2718393A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | CA2718237A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | CA2718005A1 Mmp-2 and/or mmp-9 inhibitor |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712629A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2100600A1 Extended release oral dosage composition |
| 09/16/2009 | EP2099439A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | CN101531649A Method for preparing andrographolide derivatives and preparation thereof |
| 09/16/2009 | CN101531616A Method for preparing effective ingredient with antitussive effect, namely 4-Hydroxybenzyl cyanide |
| 09/16/2009 | CN101530618A Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma |
| 09/16/2009 | CN101530584A Chinese medicinal preparation for treating malignant tumor of nasopharynx |
| 09/16/2009 | CN101530582A Traditional Chinese medicine composition for treating chronic bronchitis and preparation method thereof |
| 09/16/2009 | CN101530570A Medicine for treating respiratory disease |
| 09/16/2009 | CN101530547A Cough-relieving traditional Chinese medicinal composition and preparation method thereof |
| 09/16/2009 | CN101530543A Pink reineckia total saponin aerosol |
| 09/16/2009 | CN101530493A Medicament combination for curing respiratory diseases and application thereof |
| 09/16/2009 | CN101530474A Compound qinlan oral liquid |
| 09/16/2009 | CN101530473A Nose-dredging spraying agent and preparation method thereof |
| 09/16/2009 | CN101530472A Preparation method and application of preparation for different extraction parts of biond magnolia flower |
| 09/16/2009 | CN101530471A Preparation drug of rhinitis of biond magnolia flower and preparation method thereof |
| 09/16/2009 | CN101530461A Traditional Chinese medicine for treating nasopharyngeal cancer |
| 09/16/2009 | CN101530449A Method of preparing honeysuckle extract by applying membrane filtration technology |
| 09/16/2009 | CN101530437A Method for extracting flavonoid compound from bracken |
| 09/16/2009 | CN101530423A Medicament for treating rhinitis |
| 09/16/2009 | CN101530418A A pharmaceutical formulation for treating skin sensibility |
| 09/16/2009 | CN101530253A Sachet with function of health care and use method thereof |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/15/2009 | US7589202 Substituted pyrazoles |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2464289C Heterocyclic retinoid compounds |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/11/2009 | WO2009110519A1 Novel 1-aminocarbonylpiperidine derivative |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/11/2009 | WO2009109483A1 Leukotriene b4 inhibitors |
| 09/11/2009 | WO2009050198A3 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 09/11/2009 | WO2009040069A3 Use of bq-610 alone or in combination with helodermin as a therapeutic agent |
| 09/11/2009 | WO2009033821A3 Use of a peptide as a therapeutic agent |
| 09/11/2009 | WO2009033779A3 Nociceptin for use as a therapeutic agent |
| 09/11/2009 | WO2009033778A3 Mage-3 antigen and others for use as a therapeutic agent |
| 09/11/2009 | WO2009033775A3 Peptide alpmhir alone or in combination with peptide yvpfppf as therapeutic agent |
| 09/11/2009 | WO2009033732A3 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/11/2009 | WO2009033683A3 Galanin message associated peptide alone or in combination with minigastrin as a therapeutic agent |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | CA2717202A1 Leukotriene b4 inhibitors |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 09/10/2009 | US20090227567 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227511 Methods and compositions for treating lesions of the respiratory epithelium |